| http://dbpedia.org/ontology/abstract
|
Le mipomersen est une molécule développée comme médicament et qui est en cours de test dans le traitement des hypercholestérolémies.
, Mipomersen (INN; trade name Kynamro) is a … Mipomersen (INN; trade name Kynamro) is a drug used to treat homozygous familial hypercholesterolemia and is administered by subcutaneous injection. There is a serious risk of liver damage from this drug and it can only be prescribed in the context of a risk management plan. in the context of a risk management plan.
|
| http://dbpedia.org/ontology/alternativeName
|
Kynamro
|
| http://dbpedia.org/ontology/casNumber
|
629167-92-6
, 1000120-98-8
|
| http://dbpedia.org/ontology/chEMBL
|
502097
|
| http://dbpedia.org/ontology/drugbank
|
DB05528
|
| http://dbpedia.org/ontology/fdaUniiCode
|
18EAY4870E
, 9GJ8S4GU0M
|
| http://dbpedia.org/ontology/kegg
|
D08946
|
| http://dbpedia.org/ontology/pubchem
|
44564107
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Mipomersen_sodium_colored.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
18978054
|
| http://dbpedia.org/ontology/wikiPageLength
|
14422
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1069252261
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Messenger_RNA +
, http://dbpedia.org/resource/Ribonucleic_acid +
, http://dbpedia.org/resource/Category:Antisense_RNA +
, http://dbpedia.org/resource/Low-density_lipoprotein +
, http://dbpedia.org/resource/Liver +
, http://dbpedia.org/resource/Edema +
, http://dbpedia.org/resource/Category:Sanofi +
, http://dbpedia.org/resource/Category:Hypolipidemic_agents +
, http://dbpedia.org/resource/Transaminase +
, http://dbpedia.org/resource/Category:Therapeutic_gene_modulation +
, http://dbpedia.org/resource/Angina +
, http://dbpedia.org/resource/Pharmacokinetic +
, http://dbpedia.org/resource/Ionis_Pharmaceuticals +
, http://dbpedia.org/resource/Endonuclease +
, http://dbpedia.org/resource/International_Nonproprietary_Name +
, http://dbpedia.org/resource/Liver_damage +
, http://dbpedia.org/resource/File:Mipomersen_sodium.svg +
, http://dbpedia.org/resource/File:Mipomersen.svg +
, http://dbpedia.org/resource/Black_box_warning +
, http://dbpedia.org/resource/Translation_%28biology%29 +
, http://dbpedia.org/resource/Nucleases +
, http://dbpedia.org/resource/Exonuclease +
, http://dbpedia.org/resource/Deoxyribonucleic_acid +
, http://dbpedia.org/resource/Genzyme_Corporation +
, http://dbpedia.org/resource/Subcutaneous_injection +
, http://dbpedia.org/resource/Phosphodiester +
, http://dbpedia.org/resource/Antisense_oligonucleotide +
, http://dbpedia.org/resource/Ribonuclease_H +
, http://dbpedia.org/resource/Hepatic_steatosis +
, http://dbpedia.org/resource/Thiophosphate +
, http://dbpedia.org/resource/Familial_hypercholesterolemia +
, http://dbpedia.org/resource/Very_low-density_lipoprotein +
, http://dbpedia.org/resource/Deoxyribose +
, http://dbpedia.org/resource/Nuclease +
, http://dbpedia.org/resource/European_Medicines_Agency +
, http://dbpedia.org/resource/Risk_Evaluation_and_Mitigation_Strategies +
, http://dbpedia.org/resource/Apolipoprotein_B-100 +
|
| http://dbpedia.org/property/atcPrefix
|
10.0
|
| http://dbpedia.org/property/atcSuffix
|
AX11
|
| http://dbpedia.org/property/c
|
230
|
| http://dbpedia.org/property/casNumber
|
1000120
, 629167
|
| http://dbpedia.org/property/chembl
|
502097
|
| http://dbpedia.org/property/chemspiderid
|
24710309
|
| http://dbpedia.org/property/drugbank
|
DB05528
|
| http://dbpedia.org/property/eliminationHalfLife
|
-5259600.0
|
| http://dbpedia.org/property/excretion
|
86400.0
|
| http://dbpedia.org/property/h
|
305
|
| http://dbpedia.org/property/index2Label
|
sodium salt
|
| http://dbpedia.org/property/iupacName
|
2
|
| http://dbpedia.org/property/jmol
|
None
|
| http://dbpedia.org/property/kegg
|
D08946
|
| http://dbpedia.org/property/legalUs
|
Rx-only
|
| http://dbpedia.org/property/metabolism
|
Nucleases
|
| http://dbpedia.org/property/n
|
67
|
| http://dbpedia.org/property/na
|
19
|
| http://dbpedia.org/property/o
|
122
|
| http://dbpedia.org/property/p
|
19
|
| http://dbpedia.org/property/pregnancyUs
|
B
|
| http://dbpedia.org/property/proteinBound
|
≥90%
|
| http://dbpedia.org/property/pubchem
|
44564107
|
| http://dbpedia.org/property/routesOfAdministration
|
http://dbpedia.org/resource/Subcutaneous_injection +
|
| http://dbpedia.org/property/s
|
19
|
| http://dbpedia.org/property/smiles
|
COCCO[C@@H]1[C@H][C@H]COPO
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
XLTMQWVJFPYGMC-QVKFEXRMSA-N
|
| http://dbpedia.org/property/synonyms
|
ISIS 301012
|
| http://dbpedia.org/property/tradename
|
Kynamro
|
| http://dbpedia.org/property/unii
|
18
, 9
|
| http://dbpedia.org/property/width
|
300
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Rp +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Lipid_modifying_agents +
, http://dbpedia.org/resource/Template:Drugs.com +
, http://dbpedia.org/resource/Template:Citation_needed +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Antisense_RNA +
, http://dbpedia.org/resource/Category:Therapeutic_gene_modulation +
, http://dbpedia.org/resource/Category:Hypolipidemic_agents +
, http://dbpedia.org/resource/Category:Sanofi +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Mipomersen?oldid=1069252261&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Mipomersen.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Mipomersen_sodium.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Mipomersen_sodium_colored.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Mipomersen +
|
| owl:sameAs |
http://rdf.freebase.com/ns/m.04jhyym +
, http://sr.dbpedia.org/resource/Mipomersen +
, http://yago-knowledge.org/resource/Mipomersen +
, http://www.wikidata.org/entity/Q3315722 +
, http://fr.dbpedia.org/resource/Mipomersen +
, http://vi.dbpedia.org/resource/Mipomersen +
, http://sh.dbpedia.org/resource/Mipomersen +
, https://global.dbpedia.org/id/33pj4 +
, http://dbpedia.org/resource/Mipomersen +
|
| rdf:type |
http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Agent109190918 +
, http://dbpedia.org/class/yago/WikicatHypolipidemicAgents +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/CausalAgent100007347 +
|
| rdfs:comment |
Mipomersen (INN; trade name Kynamro) is a … Mipomersen (INN; trade name Kynamro) is a drug used to treat homozygous familial hypercholesterolemia and is administered by subcutaneous injection. There is a serious risk of liver damage from this drug and it can only be prescribed in the context of a risk management plan. in the context of a risk management plan.
, Le mipomersen est une molécule développée comme médicament et qui est en cours de test dans le traitement des hypercholestérolémies.
|
| rdfs:label |
Mipomersen
|
